ClinicalTrials.gg
RecruitingNCT07886463CAPSUpdated Oct 21, 2026

Functional Biomechanical Analysis in Patients Who Underwent Lateral Ankle Ligament Repair With Augmentation

An interventional study of Biomechanical motion analysis in Chronic Lateral Ankle Instability, sponsored by Clinique du Sport, Bordeaux Mérignac. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Clinique du Sport, Bordeaux Mérignac · Not applicable, Interventional, and Treatment

Updated Oct 21, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Chronic lateral ankle instability is a common condition in athletic populations and may lead to persistent biomechanical alterations despite appropriate management. This condition typically develops following one or more ankle sprains and is characterized by a sensation of instability, episodes of the ankle giving way, pain, or discomfort during physical or sporting activities. When conventional treatments such as rehabilitation, physiotherapy, and activity modification do not provide sufficient improvement, surgical ligament repair may be recommended.

Although this surgery generally restores ankle stability, there is currently limited evidence regarding how lower-limb function evolves following the procedure. In particular, there is no established objective reference measure to assess functional recovery and support healthcare professionals in making decisions regarding rehabilitation or return to sport.

The prospective interventional comparative analysis proposed in this study aims to evaluate surgery-induced changes in ankle and lower-limb movement and function that can be objectively quantified through biomechanical motion analysis.

02

Conditions studied

  • Chronic Lateral Ankle Instability

Keywords

  • Arthroscopic ligament repair
  • Biomechanics
  • Kinematics
  • Movement analysis
03

In context

Lead sponsor

Clinique du Sport, Bordeaux Mérignac is the lead sponsor of 11 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Standard indications for lateral ankle ligament repair surgery for chronic lateral ankle instability to conservative treatment.
  • Participation in physical activity and/or sports at least once weekly before the onset of symptoms leading to the surgical indication.

Exclusion criteria

Exclusion Criteria:

  • Concomitant surgical procedures likely to alter postoperative recovery.
  • History of major lower-limb fractures.
  • Associated injuries involving the lower limbs or lumbar spine.
  • Any other surgery performed within 6 months prior to the index procedure.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Relapsed and refractory

Relapsed: the illness came back after treatment had worked. Refractory: it did not respond to treatment, or stopped responding while still on it.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
39 participants (estimated)

Study arms

  • Experimental
    Motion analysis participants

    Participants with chronic lateral ankle instability who regularly engage in physical activity and/or sports and are scheduled to undergo lateral ankle ligament repair. Biomechanical motion analysis will be performed preoperatively and at 3 and 6 months postoperatively.

    Other: Biomechanical motion analysis

Interventions

  • OtherBiomechanical motion analysis

    The studied parameters will be categorized as follows: Kinematics * Ankle dorsiflexion/plantarflexion, inversion/eversion, and foot internal/external rotation angles * Knee flexion and valgus/varus angles * Hip flexion, adduction/abduction, and internal/external rotation angles * Trunk flexion/extension * Pelvic frontal plane tilt Kinetics and Inverse Dynamics * Ankle, knee, and hip extensor joint moments * Knee adduction moment * Positive and negative joint power at the knee and ankle * Vertical ground reaction force (vGRF) * Anterior-posterior braking and propulsion forces Spatiotemporal Parameters * Ground contact time * Stance and flight phase durations * Jump height (countermovement jump \[CMJ\] and drop jump) The three-dimensional biomechanical analysis will be performed using a 12-camera Qualisys MIQUS M3 motion capture system synchronized with two floor-embedded AMTI force platforms to quantify lower-limb kinematics, kinetics, and spatiotemporal parameters

    Also known as: three-dimensional biomedical motion analysis, Functional biomechanical analysis

06

What researchers measure

Primary outcomes

  1. Change in biomechanical parameters derived from three-dimensional motion analysis

    Change in Kinematic parameters derived from three-dimensional motion analysis between the preoperative assessment (T0), the 3-month postoperative assessment (T1), and the 6-month postoperative assessment (T2). Kinematic variables include ankle, knee, hip, trunk, and pelvic joint angles (°). Data will be collected using a 12-camera Qualisys MIQUS M3 optoelectronic motion capture system (Qualisys AB, Gothenburg, Sweden).

    Time frame: From enrollement to 6 months after surgery

Secondary outcomes

  1. Changes in Kinetic Moments Measurements

    Kinetic and inverse dynamics measures at T0, T1, and T2 include : * Ankle, knee, and hip extensor joint moments (N·m/kg) * Knee adduction moment (N·m/kg)

    Time frame: From enrollement to 6 months after surgery

  2. Changes in Spatiotemporal Parameters

    Spatiotemporal parameters measured at T0, T1, and T2 include: * Ground contact time (s) * Stance phase duration (s) * Flight phase duration (s)

    Time frame: From enrollement to 6 months after surgery

  3. Limb Symmetry Index (LSI) for selected biomechanical parameters

    Inter-limb symmetry will be expressed as a Limb Symmetry Index (LSI), calculated as: LSI = (Operated limb value / Contralateral limb value) × 100 Values will be expressed as percentages (%). Separate analyses will be performed for each predefined biomechanical parameter.

    Time frame: From enrollement to 6 months after surgery

  4. Change in Limb Symmetry Index over time

    Evolution of the Limb Symmetry Index (LSI) between baseline (T0), 3 months (T1), and 6 months (T2) following surgery.

    Time frame: From inclusion to 6 months post-surgery

  5. Countermovement Jump (CMJ) Height

    Vertical jump height measured during the Countermovement Jump (CMJ), expressed in centimeters.

    Time frame: From Inclusion to 6 months post-surgery

  6. Drop Jump Height

    Vertical jump height measured during the Drop Jump task, expressed in centimeters.

    Time frame: From enrollement to 6 months after surgery

  7. Changes in Kinetic Joint Power Measurements

    Kinetic and inverse dynamics measures at T0, T1, and T2 include : Positive and negative joint power at the knee and ankle (W/kg)

    Time frame: From enrollement to 6 months after surgery

  8. Changes in Kinetic Vertical ground reaction force Measurements

    Kinetic and inverse dynamics measures at T0, T1, and T2 include : Vertical ground reaction force (vGRF) (N)

    Time frame: From enrollement to 6 months after surgery

  9. Changes in Kinetic Reaction Forces Measurements

    Kinetic and inverse dynamics measures at T0, T1, and T2 include : Anterior-posterior braking and propulsive ground reaction forces (N/kg)

    Time frame: From enrollement to 6 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Jun 2028, 20 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2026
First posted
Oct 21, 2026
StartEst.
Oct 20, 2026
Primary completionEst.
Jun 30, 2028
CompletionEst.
Jun 30, 2028
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07886463
Lead sponsor
Clinique du Sport, Bordeaux Mérignac
Responsible party
Sponsor
First posted
Oct 21, 2026
Start date
Oct 20, 2026 (estimated)
Primary completion
Jun 30, 2028 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Oct 21, 2026

Study contacts

Marion Mandon, PhD
Contact
DRC@vivalto-sante.com
+33 6 78 27 76 72
Emma Escoffier, Master
Contact
eescoffier@vivalto-santé.com
+ 33 6 88 92 33 17
Guillaume Cordier, MD
principal investigator · Clinique du sport

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion